Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Feb 13, 2018 (9 years ago)

Calcium Acetate Capsules

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Presence of Foreign Tablets/Capsules

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02

Affected NDC 29033-0026-02

Compare with the code on your package — it is the most precise check available.

Recalling firm
Nostrum Laboratories Inc
NDC code
29033-026-02
Origin
MO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0473-2018 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Nostrum Laboratories Inc

All 2018 recalls
Class II · Moderate risk

Sucralfate Tablets

CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

Ongoing cGMP deviation Nostrum Laboratories, Inc. NDC 29033-0003-01 D-0547-2025

Other particulate / foreign matter recalls from 2018

All particulate / foreign matter recalls
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-644-01 D-0358-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-633-01 D-0357-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-622-01 D-0356-2019